Medical Developments International Ltd
ASX:MVP

Watchlist Manager
Medical Developments International Ltd Logo
Medical Developments International Ltd
ASX:MVP
Watchlist
Price: 0.62 AUD Market Closed
Market Cap: 69.8m AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

MVP Price Targets Summary
Medical Developments International Ltd

Wall Street analysts forecast MVP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MVP is 0.82 AUD with a low forecast of 0.81 AUD and a high forecast of 0.84 AUD.

MVP Lowest Forecast
Wall Street Target
0.81 AUD
30% Upside
MVP Average Forecast
Wall Street Target
0.82 AUD
32% Upside
MVP Highest Forecast
Wall Street Target
0.84 AUD
35% Upside
Lowest
Price Target
0.81 AUD
30% Upside
Average
Price Target
0.82 AUD
32% Upside
Highest
Price Target
0.84 AUD
35% Upside
Medical Developments International Ltd Competitors:
Price Targets
C
2M7C
China Medical System Holdings Ltd
4% Upside
4568
Daiichi Sankyo Co Ltd
75% Upside
AXSM
Axsome Therapeutics Inc
61% Upside
LLY
Eli Lilly and Co
29% Upside
C
2M7C
China Medical System Holdings Ltd
4% Upside
4568
Daiichi Sankyo Co Ltd
75% Upside
AXSM
Axsome Therapeutics Inc
61% Upside
LLY
Eli Lilly and Co
29% Upside
234080
JW Life Science Corp
32% Upside
W
016580
Whanin Pharm Co Ltd
38% Upside
6996
Antengene Corporation Ltd
22% Upside

Revenue
Forecast

Revenue Estimate
Medical Developments International Ltd

For the last 8 years the compound annual growth rate for Medical Developments International Ltd's revenue is 10%. The projected CAGR for the next 3 years is 15%.

10%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Medical Developments International Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Medical Developments International Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
What are analyst estimates?

See Also

Summary
MVP intrinsic value, competitors valuation, and company profile.
DCF Valuation
MVP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MVP stock valuation using valuation multiples.
Wall Street Estimates
MVP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MVP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MVP's stock price target?
Price Target
0.82 AUD

According to Wall Street analysts, the average 1-year price target for MVP is 0.82 AUD with a low forecast of 0.81 AUD and a high forecast of 0.84 AUD.

What is Medical Developments International Ltd's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Medical Developments International Ltd's revenue is 10%. The projected CAGR for the next 3 years is 15%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 260,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.